Hexaminolevulinate blue-light cystoscopy in non-muscle-invasive bladder cancer: review of the clinical evidence and consensus statement on appropriate use in the USA. (Q38253205)

From Wikidata

Jump to navigation Jump to search

scientific article published on 23 September 2014

Language	Label	Description	Also known as
English	Hexaminolevulinate blue-light cystoscopy in non-muscle-invasive bladder cancer: review of the clinical evidence and consensus statement on appropriate use in the USA.	scientific article published on 23 September 2014

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25245244%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

1 reference

Europe PubMed Central

Hexaminolevulinate blue-light cystoscopy in non-muscle-invasive bladder cancer: review of the clinical evidence and consensus statement on appropriate use in the USA (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25245244%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Siamak Daneshmand

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25245244%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

Bernard H Bochner

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25245244%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

author name string

Anne K Schuckman

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25245244%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

Michael S Cookson

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25245244%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

Tracy M Downs

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25245244%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

Leonard G Gomella

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25245244%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

H Barton Grossman

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25245244%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

Ashish M Kamat

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25245244%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

Badrinath R Konety

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25245244%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

Cheryl T Lee

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25245244%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

Kamal S Pohar

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25245244%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

Raj S Pruthi

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25245244%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

Matthew J Resnick

13

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25245244%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

Norm D Smith

14

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25245244%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

J Alfred Witjes

15

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25245244%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

Mark P Schoenberg

16

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25245244%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

Gary D Steinberg

17

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25245244%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

language of work or name

0 references

publication date

23 September 2014

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25245244%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

Nature Reviews Urology

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25245244%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25245244%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25245244%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

589-596

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25245244%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials.

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2014.245

21 January 2018

Guideline for the management of nonmuscle invasive bladder cancer (stages Ta, T1, and Tis): 2007 update

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2014.245

21 January 2018

The costs of non-muscle invasive bladder cancer

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2014.245

21 January 2018

The effect of restaging transurethral resection on recurrence and progression rates in patients with nonmuscle invasive bladder cancer treated with intravesical bacillus Calmette-Guérin

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2014.245

21 January 2018

An evaluation to define the role of repeat transurethral resection in a treatment algorithm for non-muscle-invasive bladder cancer

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2014.245

21 January 2018

Effect of routine repeat transurethral resection for superficial bladder cancer: a long-term observational study

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2014.245

21 January 2018

ICUD-EAU International Consultation on Bladder Cancer 2012: Non-muscle-invasive urothelial carcinoma of the bladder.

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2014.245

21 January 2018

Improved detection of urothelial carcinoma in situ with hexaminolevulinate fluorescence cystoscopy

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2014.245

21 January 2018

Improved detection and treatment of bladder cancer using hexaminolevulinate imaging: a prospective, phase III multicenter study

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2014.245

21 January 2018

A phase III, multicenter comparison of hexaminolevulinate fluorescence cystoscopy and white light cystoscopy for the detection of superficial papillary lesions in patients with bladder cancer.

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2014.245

21 January 2018

A comparison of hexaminolevulinate fluorescence cystoscopy and white light cystoscopy for the detection of carcinoma in situ in patients with bladder cancer: a phase III, multicenter study.

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2014.245

21 January 2018

Hexaminolevulinate guided fluorescence cystoscopy reduces recurrence in patients with nonmuscle invasive bladder cancer

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2014.245

21 January 2018

Fluorescence-guided transurethral resection of bladder tumours reduces bladder tumour recurrence due to less residual tumour tissue in Ta/T1 patients: a randomized two-centre study

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2014.245

21 January 2018

Long-term decrease in bladder cancer recurrence with hexaminolevulinate enabled fluorescence cystoscopy

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2014.245

21 January 2018

Effects of fluorescent light-guided transurethral resection on non-muscle-invasive bladder cancer: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2014.245

21 January 2018

Therapeutic outcome of fluorescence cystoscopy guided transurethral resection in patients with non-muscle invasive bladder cancer: a meta-analysis of randomized controlled trials

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2014.245

21 January 2018

Prospective randomized trial of hexylaminolevulinate photodynamic-assisted transurethral resection of bladder tumour (TURBT) plus single-shot intravesical mitomycin C vs conventional white-light TURBT plus mitomycin C in newly presenting non-muscle-

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2014.245

21 January 2018

Photodynamic diagnosis of non-muscle-invasive bladder cancer with hexaminolevulinate cystoscopy: a meta-analysis of detection and recurrence based on raw data

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2014.245

21 January 2018

Photodynamic diagnosis in non-muscle-invasive bladder cancer: a systematic review and cumulative analysis of prospective studies

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2014.245

21 January 2018

The role of hexylaminolaevulinate in the diagnosis and follow-up of non-muscle-invasive bladder cancer

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2014.245

21 January 2018

Safety of hexaminolevulinate for blue light cystoscopy in bladder cancer. A combined analysis of the trials used for registration and postmarketing data

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2014.245

21 January 2018

Role of hexaminolevulinate-guided fluorescence cystoscopy in bladder cancer: critical analysis of the latest data and European guidance

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2014.245

21 January 2018

Fluorescence-guided transurethral resection of bladder cancer using hexaminolevulinate: analysis of health economic impact in Sweden

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2014.245

21 January 2018

The economic benefit of photodynamic diagnosis in non-muscle invasive bladder cancer

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2014.245

21 January 2018

Hexyl aminolevulinate: in the detection of bladder cancer

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2014.245

21 January 2018

Retrospective analysis of transurethral resection, second-look resection, and long-term chemo-metaphylaxis for superficial bladder cancer: indications and efficacy of a differentiated approach

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2014.245

31 March 2020

The value of a second transurethral resection for T1 bladder cancer

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2014.245

31 March 2020

Results of second-look resection after primary resection of T1 tumour of the urinary bladder

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2014.245

31 March 2020

Second transurethral resection of superficial transitional cell carcinoma of the bladder: a must even for experienced urologists

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2014.245

31 March 2020

Second resection and prognosis of primary high risk superficial bladder cancer: is cystectomy often too early?

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2014.245

31 March 2020

Use of restaging bladder tumor resection for bladder cancer among Medicare beneficiaries

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2014.245

31 March 2020

Restaging transurethral resection of high risk superficial bladder cancer improves the initial response to bacillus Calmette-Guerin therapy

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2014.245

31 March 2020

Clinical and cost effectiveness of hexaminolevulinate-guided blue-light cystoscopy: evidence review and updated expert recommendations.

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2014.245

31 March 2020

Photodynamic diagnostics and noninvasive bladder cancer: is it cost-effective in long-term application? A Germany-based cost analysis

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2014.245

31 March 2020

The health economics of bladder cancer: a comprehensive review of the published literature.

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2014.245

31 March 2020

A prospective evaluation of second transurethral resection in non-muscle invasive bladder tumors

1 reference

https://pubmed.ncbi.nlm.nih.gov/25245244

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The cost-effectiveness of blue light cystoscopy in bladder cancer detection: United States projections based on clinical data showing 4.5 years of follow up after a single hexaminolevulinate hydrochloride instillation

1 reference

https://pubmed.ncbi.nlm.nih.gov/25245244

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Photodynamic diagnosis for superficial bladder cancer: do all risk-groups profit equally from oncological and economic long-term results?

1 reference

https://pubmed.ncbi.nlm.nih.gov/25245244

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Is there a learning curve for photodynamic diagnosis of bladder cancer with hexaminolevulinate hydrochloride?

1 reference

https://pubmed.ncbi.nlm.nih.gov/25245244

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Blue light cystoscopy for detection and treatment of non-muscle invasive bladder cancer.

1 reference

https://pubmed.ncbi.nlm.nih.gov/25245244

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1038/NRUROL.2014.245

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25245244%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25245244%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38253205&oldid=2201472076"